Safety and efficacy of low‐dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study

Publisher: John Wiley & Sons Inc

E-ISSN: 1538-7836|10|11|2291-2297

ISSN: 1538-7933

Source: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.10, Iss.11, 2012-11, pp. : 2291-2297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content